
PARENTAL ORIGIN AND CELL STAGE ERRORS IN X-CHROMOSOME POLYSOMY 49,XXXXY Guzel AI1,*, Demirhan O1, Pazarbasi A1, Yuksel B2
*Corresponding Author: Ali Irfan Guzel, Ph.D., Department of Medical Biology and Genetics, Faculty of Medicine, Çukurova University, 01330 Adana, Turkey; Tel.: +90-322-338-70-68; Fax: +90-322-338-70-65; E-mail: aliirfan@cu.edu.tr
page: 45
|
INTRODUCTION
The tetrasomy X (49,XXXXY) syndrome is a rare X-chromosome polysomy with an estimated incidence of 1 in 85,000 male births [1]. The chromosomal constitution and clinical findings were described by Fraccaro et al. in 1960 [2]. Tetrasomy X has been considered as the most severe variant of Klinefelter’s syndrome which is a common sex chromosomal abnormality caused by the presence of one additional X chromosome in males and has a prevalence of 1 in 500 [1-4]. The most common sex chromosome aberrations in live births are 47,XXY, 47,XXX, and 47,XYY [5]. However, rare syndrome variants with X and Y polysomy, mosaicisms and aberrant chromosomes have been reported, including 48,XXXY, 48,XXYY, 49XXXXY, 47,XXY/ 48,XXXY and 48,XXXY/49,XXXXY [6,7]. The clinical features of Klinefelter’ syndrome are variable but often include infertility, gynecomastia, eunuchoidism, small testes and penis and hypergonadotropic hypogonadism. The extra X chromosome in these patients accounts for the clinical phenotype, but this ranges from mild (only infertility) to more severe with physical anomalies and mental retardation. The classical features of 49,XXXXY syndrome are growth and mental retardation, severe speech impairment, multiple skeletal defects, and dental, craniofacial and genital abnormalities. These patients have also phenotypic similarities such as strabismus, microcephaly, epicanthal folds, hypertelorism, cleft palate and heart disease [2,8,9]. We studied a patient with the 49,XXXXY karyotype, verified and identified by quantitative fluorescent polymerase chain reaction (QF-PCR) amplification of seven short tandem repeat (STR) markers located on X and Y chromosomes, and two additional regions (AMXY for X and Y, and SRY for Y chromosomes).
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|